Edward White
Stock Analyst at HC Wainwright & Co.
(1.49)
# 3,441
Out of 5,182 analysts
338
Total ratings
29.97%
Success rate
-8.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $14.86 | +122.07% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $5.95 | +185.71% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $3.29 | +355.93% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $3.76 | +59.57% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $0.55 | +2,809.62% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $1.76 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $30.19 | +164.99% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $1.77 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $6.67 | +199.85% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $4.78 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $5.04 | +217.46% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $6.63 | +277.07% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.97 | +727.13% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $15.92 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $6.43 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $33.39 | +64.72% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $24.64 | +106.98% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $6.97 | +0.43% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $7.21 | +676.70% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $101 → $52 | $10.20 | +409.80% | 4 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.68 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $30.91 | -2.94% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $1.15 | +943.48% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $14.86
Upside: +122.07%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $5.95
Upside: +185.71%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $3.29
Upside: +355.93%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $3.76
Upside: +59.57%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $0.55
Upside: +2,809.62%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.76
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $30.19
Upside: +164.99%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.77
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $6.67
Upside: +199.85%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $4.78
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $5.04
Upside: +217.46%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $6.63
Upside: +277.07%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $0.97
Upside: +727.13%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $15.92
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $6.43
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $33.39
Upside: +64.72%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $24.64
Upside: +106.98%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $6.97
Upside: +0.43%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $7.21
Upside: +676.70%
Aug 5, 2022
Downgrades: Neutral
Price Target: $101 → $52
Current: $10.20
Upside: +409.80%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.68
Upside: -
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $30.91
Upside: -2.94%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $1.15
Upside: +943.48%